Literature DB >> 8882140

Down syndrome with coexistent gout: report of six patients and possible reasons for the scarcity of descriptions of this association.

N Kamatani, H Yamanaka, S Totokawa, S Kashiwazaki, M Higurashi.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8882140      PMCID： PMC1010266          DOI： 10.1136/ard.55.9.649

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Serum uric acid in mongolism.

Authors:  R W FULLER; M W LUCE; E T MERTZ
Journal:  Science       Date:  1962-09-14       Impact factor: 47.728

Review 2.  Arthritis in Down's syndrome.

Authors:  J E Dacre; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

3.  Hyperuricemia in Down's syndrome.

Authors:  S S Pant; H W Moser; S M Krane
Journal:  J Clin Endocrinol Metab       Date:  1968-04       Impact factor: 5.958

4.  Hyperuricemia in mongolism.

Authors:  J M Kaufman; W M O'Brien
Journal:  N Engl J Med       Date:  1967-04-27       Impact factor: 91.245

5.  Leucocyte function in Down's syndrome and acute leukaemia.

Authors:  L Gregory; R Williams; E Thompson
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

6.  [Gout and mongolism. Apropos of a case].

Authors:  J Cayla; J Rondier; C Auscher; C Perreau; A de Gery
Journal:  Rev Rhum Mal Osteoartic       Date:  1974-03

7.  Mortality and survival for Down syndrome in Japan.

Authors:  M Masaki; M Higurashi; K Iijima; N Ishikawa; F Tanaka; T Fujii; Y Kuroki; I Matsui; K Iinuma; N Matsuo; K Takeshita; S Hashimoto
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

8.  Uric acid metabolism in two patients with coexistent Down's syndrome and gout.

Authors:  M L Ciompi; L M Bazzichi; D Bertolucci; M R Mazzoni; P Barbieri; S Mencacci; D Macchia; G Mariani
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

9.  A case of gouty arthritis associated with Down's syndrome.

Authors:  Y Nishida; I Akaoka; T Nishizawa; M Maruki; T Aikawa; T Mitamura; R Yokohari; Y Horiuchi
Journal:  J Ment Defic Res       Date:  1976-12

10.  Preliminary criteria for the classification of the acute arthritis of primary gout.

Authors:  S L Wallace; H Robinson; A T Masi; J L Decker; D J McCarty; T F Yü
Journal:  Arthritis Rheum       Date:  1977-04
  10 in total
  3 in total

1.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

2.  Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Masataka Honda; Hideki Horiuchi; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hisashi Yamanaka; Shuichi Ito
Journal:  BMC Pediatr       Date:  2021-12-18       Impact factor: 2.125

3.  Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Shuichi Ito; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hideki Horiuchi; Hisashi Yamanaka; Masataka Honda
Journal:  BMC Pediatr       Date:  2020-10-15       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.